Compare UNF & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNF | VKTX |
|---|---|---|
| Founded | 1936 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.4B |
| IPO Year | 1994 | 2014 |
| Metric | UNF | VKTX |
|---|---|---|
| Price | $293.94 | $34.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $238.33 | $95.86 |
| AVG Volume (30 Days) | 136.5K | ★ 2.4M |
| Earning Date | 04-01-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ 2.70 | N/A |
| EPS | ★ 4.11 | N/A |
| Revenue | ★ $1,696,489,000.00 | N/A |
| Revenue This Year | $3.69 | N/A |
| Revenue Next Year | $3.53 | N/A |
| P/E Ratio | $70.49 | ★ N/A |
| Revenue Growth | ★ 6.63 | N/A |
| 52 Week Low | $147.66 | $22.96 |
| 52 Week High | $295.60 | $43.15 |
| Indicator | UNF | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 72.75 | 44.70 |
| Support Level | $258.79 | $34.03 |
| Resistance Level | $295.60 | $36.77 |
| Average True Range (ATR) | 5.51 | 2.05 |
| MACD | 1.54 | -0.66 |
| Stochastic Oscillator | 95.05 | 3.75 |
UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.